InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Llorens Josep, Directeur Exécutif. Director active across 2 companies, notably HAEMONETICS CORP. Cumulatively, 14 disclosures have been logged. Split: 0 buy · 6 sells. Total volume traded: €175k. Activity tracked since 17 May 2021. The latest transaction was disclosed on 28 May 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Llorens Josep
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
14,140 shares0Common StockSEC:0001127602-24-016813:0
822 shares@ US$94.8212.8% of flowCommon StockSEC:0001127602-24-016169:0
258 shares@ US$96.494.1% of flowCommon StockSEC:0001127602-24-015868:0
2,391 shares@ US$56.5721.4% of flowCommon StockSEC:0001127602-23-021080:0
1,423 shares@ US$83.3419.6% of flowCommon StockSEC:0001127602-23-016313:0
3,084 sharesCommon StockSEC:0001127602-23-015937:0
113 shares@ US$88.161.6% of flowCommon StockSEC:0001127602-23-015738:0
2,391 shares@ US$56.5722.2% of flowCommon StockSEC:0001127602-23-002187:0
101 shares@ US$73.781.3% of flowCommon StockSEC:0001127602-22-022153:0
1,418 shares@ US$59.100.0030% mcap82.8% of flowCommon StockSEC:0001127602-22-015369:0
107 shares@ US$56.100.0002% mcap6.0% of flowCommon StockSEC:0001127602-22-014988:0
100 shares@ US$64.611.0% of flowCommon StockSEC:0000899243-21-035451:0
3,535 sharesCommon StockSEC:0001127602-21-017681:0
114 shares@ US$55.970.9% of flowCommon StockSEC:0001127602-21-017271:0
14 of 14 declarations
About Llorens Josep
Llorens Josep is a Director Exécutif and EVP, Global Manufacturing at HAEMONETICS CORP (XNAS). The declarant has 14 filings in total; among the sampled recent filings, the transactions are disposals for a total of EUR 174918, over the period from 2021-05-18 to 2024-05-29.
